Introduction of the biosimilar trastuzumab and its impact on patients and services

Geof Saunders speaks to ecancer at the 2019 Biosimilars Educational Advanced Masterclass for Pharmacists (P-BEAM) in Zurich about introducing a biosimilar of trastuzumab into clinical practice. He speaks about the processes behind the implementation of this biosimilar, which included a variety of staff across different disciplines. Saunders also reflects on the feedback from this, particulary from patients and how these processes could be improved for the future. Sign up to ecancer for free to receive tailored email alerts for more videos like this. ecancer.org/account/register.php